Pramodini Medicare Ltd.
PRAMODINISME
Overview
Pramodini Medicare Limited is an India-based diagnostics service provider delivering technology-enabled radiology, clinical laboratory and nuclear medicine services through in-hospital diagnostic centres and standalone facilities. The company operates largely via partnership/MoU-based models with government hospitals (PPP), private hospitals, and PSUs, and also runs private centres including a main hub and processing laboratory in Vijayawada with 24x7 teleradiology support.
Opening Date
Aug 12, 2026
Closing Date
Aug 14, 2026
Listing Date
Aug 19, 2026
IPO Type
SME
IPO Status
Closed
Issue Size
69.04 Cr
Fresh Issue
63.14 Cr
Offer for Sale
5.9 Cr
Price Band
₹110 - ₹118
Lot Size
1200
IPO Timeline
Financials
Revenue
Profit After Tax (PAT)
Use of IPO funds
Key Performance Indicator
P/E Ratio
11.34
EPS
10.41
ROE
39.08%
ROCE
34.66%
RONW
32.69%
Debt to Equity Ratio
0.34
PAT Margin
27.9%
EBITDA Margin
49.61%
P/B
3.71
Bull vs Bear
Bull case
- •
Government-linked contracts are a scale advantage. If MOUs renew, it supports steady volumes without spending heavily on building walk-in demand.
- •
A multi-model setup (PPP, private, standalone, PSU) reduces reliance on one channel, so weakness in one route may be offset by others.
- •
Heavy investment in imaging and IT systems can improve speed and consistency, which matters because hospitals value reliable reports and turnaround time.
Bear case
- •
Over half of revenue depends on PPP MOUs. Non-renewal, contract changes, or slow government payments can squeeze cash and disrupt operations.
- •
Almost all revenue comes from radiology. Any equipment downtime, regulation issue, or technology shift can hit earnings harder than a diversified lab company.
- •
Revenue is concentrated in Andhra Pradesh. Local disruptions or weaker hospital demand there could drag overall results despite newer states contributing.
Net takeaway
For a long-term holder, the story is a hospital-partner diagnostics platform that has built scale through government and institutional tie-ups, supported by big imaging investments. That can create durable demand, but it also means dependence on renewals, payment cycles, and strict compliance in radiology-heavy services. Geographic concentration adds another layer of risk. The main thing to monitor over time is how quickly trade receivables get collected, especially from government customers.

